NASDAQ:HSIC - Henry Schein Stock Price, News, & Analysis

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Henry Schein's stock split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has authorized a share buyback plan on Thursday, December 13th 2018, which permits the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 3.1% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's leadership believes its stock is undervalued.

Henry Schein, Inc. (NASDAQ:HSIC) announced its earnings results on Tuesday, November, 6th. The company reported $1.03 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.01 by $0.02. The company earned $3.28 billion during the quarter, compared to analysts' expectations of $3.37 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The company's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.87 EPS. View Henry Schein's Earnings History.

Henry Schein is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Henry Schein.

Henry Schein issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $4.06-4.14 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.12.

16 brokerages have issued 1 year price objectives for Henry Schein's shares. Their forecasts range from $66.00 to $102.00. On average, they expect Henry Schein's share price to reach $83.9993 in the next year. This suggests a possible upside of 5.0% from the stock's current price. View Analyst Price Targets for Henry Schein.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Henry Schein.

Press coverage about HSIC stock has been trending positive on Wednesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Henry Schein earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the near future.

Henry Schein saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 14,216,283 shares, a drop of 12.0% from the December 14th total of 16,154,837 shares. Based on an average daily volume of 1,569,236 shares, the days-to-cover ratio is presently 9.1 days. Approximately 9.5% of the company's stock are sold short. View Henry Schein's Current Options Chain.

Some companies that are related to Henry Schein include Vertex Pharmaceuticals (VRTX), HCA Healthcare (HCA), Illumina (ILMN), Regeneron Pharmaceuticals (REGN), Zoetis (ZTS), Humana (HUM), Baxter International (BAX), Edwards Lifesciences (EW), Actelion (ALIOF), ESSILOR INTL S/S (ESLOY), FRESENIUS SE &/S (FSNUY), ASTELLAS PHARMA/ADR (ALPMY), Takeda Pharmaceutical (TKPYY), Centene (CNC) and Alexion Pharmaceuticals (ALXN).

Henry Schein's stock is owned by a number of of retail and institutional investors. Top institutional investors include Fenimore Asset Management Inc. (0.36%), Riverbridge Partners LLC (0.26%), Retirement Systems of Alabama (0.24%), Sheets Smith Wealth Management (0.05%), JLB & Associates Inc. (0.04%) and State of Alaska Department of Revenue (0.04%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Lorelei Mcglynn, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Paul Brons, Paul Rose, Philip A Laskawy, Stanley M Bergman and Steven Paladino. View Institutional Ownership Trends for Henry Schein.

HSIC stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Gulf International Bank UK Ltd, DNB Asset Management AS, Neville Rodie & Shaw Inc., Louisiana State Employees Retirement System, Fenimore Asset Management Inc., First Hawaiian Bank and Gateway Investment Advisers LLC. Company insiders that have sold Henry Schein company stock in the last year include David Mckinley, Mark E Mlotek, Michael S Ettinger, Paul Brons, Stanley M Bergman and Steven Paladino. View Insider Buying and Selling for Henry Schein.

HSIC stock was bought by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Boston Advisors LLC, Dorsey Wright & Associates, State of Alaska Department of Revenue, JLB & Associates Inc., CHURCHILL MANAGEMENT Corp, Coastline Trust Co and Sheets Smith Wealth Management. View Insider Buying and Selling for Henry Schein.

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HSIC stock can currently be purchased for approximately $79.98.

Henry Schein has a market capitalization of $12.19 billion and generates $12.46 billion in revenue each year. The company earns $406.29 million in net income (profit) each year or $3.60 on an earnings per share basis. Henry Schein employs 22,000 workers across the globe.

The official website for Henry Schein is http://www.henryschein.com.

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]